ChoudharySMcLeodMTorchiaD, et al.Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome. J Clin Aesthet Dermatol2013; 6: 31–37.
2.
DeARajagopalanMSardaA, et al.Drug reaction with eosinophilia and systemic symptoms: an update and review of recent literature. Indian J Dermatol2018; 63: 30–40.
3.
BocquetHBagotMRoujeauJC. Drug-induced pseudolymphoma and drug hypersensitivity syndrome (drug rash with eosinophilia and systemic symptoms: DRESS). Semin Gutan Med Surg1996; 15: 250–257.
4.
PrylińskaMDworakowska-KicińskaMKrogulskaA. Dress syndrome in 7-year-old male child – case report. J Mother Child2021; 24: 45–48.
5.
ShioharaTKanoY. Drug reaction with eosinophilia and systemic symptoms (DRESS): incidence, pathogenesis and management. Expert Opin Drug Saf2017; 16: 139–147.
6.
ChoudharySMcLeodMTorchiaD, et al.Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome. J Clin Aesthet Dermatol2013; 6: 31–37.
7.
SharmaANShweSRaviV, et al.Characterizing DRESS syndrome recurrence: a systematic review. Arch Dermatol Res2022; 314: 721–728.
8.
SchunkertEMDivitoSJ. Updates and insights in the diagnosis and management of DRESS syndrome – current dermatology reports. Curr Dermatol Rep2021; 10: 192–204.
9.
DeARajagopalanMSardaA, et al.Drug reaction with eosinophilia and systemic symptoms: an update and review of recent literature. Indian J Dermatol2018; 63: 30–40.
10.
KitoYItoTTokuraY, et al.High-dose intravenous immunoglobulin monotherapy for drug-induced hypersensitivity syndrome. Acta Derm Venereol2012; 92: 100–101.